Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan

BACKGROUND: Although immune checkpoint inhibitors (ICIs) are promising in the treatment of advanced cancer, their use is associated with immune-related adverse events (irAEs) that affect endocrine organ systems. Although development of irAEs was associated with improved cancer-specific survival, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910101/
https://www.ncbi.nlm.nih.gov/pubmed/33654416
http://dx.doi.org/10.2147/DMSO.S289446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910101/
https://www.ncbi.nlm.nih.gov/pubmed/33654416
http://dx.doi.org/10.2147/DMSO.S289446

Ejemplares similares